Rituxy 500mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Rituximab (500mg)
Overview Rituxy 500mg Injection
Ritumab 500mg is administered intravenously to manage various conditions, including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis. Administration must be under strict medical supervision, with dosage and frequency determined solely by the physician based on the specific condition being treated; this may fluctuate over the course of therapy. Precise adherence to the prescribed regimen is crucial, as incorrect usage or overdosage can lead to severe adverse reactions. While therapeutic benefits may not be immediately apparent (often taking weeks or months), discontinuation should only occur under explicit medical guidance. Commonly reported side effects encompass headache, fatigue, swelling, infections, and alopecia. A reduction in blood cell counts, potentially increasing infection risk, is a possibility; therefore, regular blood tests, including hepatitis B monitoring, are mandatory. Prior to commencing treatment, patients should inform their physician of any pre-existing heart or liver conditions, planned surgical procedures or immunizations, and all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is strongly advised throughout treatment.
Primary Ingredients of Rituxy 500mg Injection
There is no text provided to rephrase.
Uses of Rituxy 500mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin lymphoma.
Major Benefits of Rituxy 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rituxy 500mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Rituxy 500mg Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-administration is strictly prohibited.
How Rituxy 500mg Injection works:
MabThera 500mg, a monoclonal antibody injection, neutralizes the aberrant function of B lymphocytes, thereby treating rheumatoid arthritis and specific malignancies.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while using Rituximab 500mg Injection. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rituximab 500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Rituximab 500mg Injection safely. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of a 500mg Rituxan injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of 500mg Rituxy injections in individuals with kidney disease appears to pose minimal risk. Existing evidence indicates that dose modification might not be necessary for this patient population. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Rituxy 500mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised. Rituxy 500mg Injection is contraindicated in patients with active liver disease or a history of viral hepatitis due to the risk of infection recurrence.
What if you forget to take Rituxy 500mg Injection :
Should you forget a dose of Rituximab 500mg injection, seek medical advice immediately.
Facts to Know About Rituxy 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Anti-CD20 Therapy |
3,018 People bought this recently